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RefVet Portal allows immediate online access to patient 
records
Cornell University Hospital for Animals is proud to announce the launch of the newly improved 
Cornell RefVet Portal. CUHA's RefVet Portal gives referring veterinarians convenient and immediate 
online access to their patient’s medical records, reports, and results. RefVet has been updated and 
redesigned to better suit your needs in the interim as we work on the larger website project.
New features include:
• Greater security with the ability to create and manage your own username and password
• Search for your cases by patient name, client first or last name, case number
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• Filter by last admission date
• Quickly request a consult or ask a question regarding 
a mutual patient
• Expanded access to reports
• Save reports as pdfs
To get started using RefVet today go to 
https://secure.vet.cornell.edu/cuha_refvet/ and register your 
account.
*Note:
• If vou were registered with the previous version of RefVet. vou will need to re-reaister
vour account.
• The client must list vou as their referring veterinarian for access to that individual 
patient’s records.
Please feel free to share RefVet with your colleagues and send your comments and feedback to vet- 
hosp@cornell.edu
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Case Study: canine patient with immune-mediated 
thrombocytopenia
Methos, a 9-year-old neutered male Labrador retriever mix, had been more lethargic and panting 
more frequently since around the end of May. "He's normally a very active dog," says owner Roxann 
Pressler, "but he had become really lethargic, and didn't want to eat." Pressler took him to his primary 
care veterinarian, Home Veterinary Care in Elmira, NY, who documented a severe thrombocytopenia 
anda mild regenerative anemia on a complete blood count. He also tested weakly positive for 
Anaplasma phagocytophilum on a 4Dx. He was started on oral prednisolone and antibiotics but failed 
to improve, prompting the local veterinarian to recommend Methos be seen at CUHA for further 
treatment and evaluation.
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At the CUHA ER, Methos presented with melena, hematochezia, and lethargy.The only abnormal 
findings on physical examination were petechia (pinpoint bleeding) on his pale pink gums, areas of 
bruising (ecchymoses) on his ventral abdomen, and black tarry stool on the thermometer. Quick 
assessment tests revealed a moderate anemia and severe hypoproteinemia. Coagulation testing 
revealed no abnormalities. A complete blood count submitted at this time revealed a severely low 
platelet count of 11 thou/uL. Thoracic radiographs and abdominal ultrasound were unremarkable. 
Main differentials considered at this time included immune-mediated thrombocytopenia (ITP) or
"V, ^rickettsial infection.
|The following day, Methos was transferred to Cornell's Internal Medicine 
^Service, where Methos’ clinical team, including Dr. John Lucy and DVM 
*ftp|student Stephanie Seller, diagnosed him with ITP, while also treating the 
^^^ricke tts ia l infection.. Methos had become hypovolemic and severely 
[ ^ ^ ^ ^ a n e m ic  overnight, so they administered a packed red blood cell
ransfusion and fluid bolus to boost his red blood cell count and improve 
his circulation. Vincristine treatment was initiated as a rescue drug for his 
thrombocytopenia, along with immunomodulatory medications (steroids and mycophenolate), 
doxycycline, and gastroprotecants.
I. '
■ i  m
After several days, Methos’ platelet count had not improved and he had new signs of bleeding 
including retinal hemorrhages. After an additional red blood cell transfusion, his clinical team decided 
to use a second rescue drug, human intravenous immunoglobulins (hIVIG). He had no adverse effects 
following treatment, and within 24 hours his platelet counts were normalizing. He was discharged to 
his owner, with frequent follow-ups as his immunomodulatory drugs were slowly tapered.
While it remains unknown why Methos developed antibodies against his platelets, he is now doing 
well, with regular monitoring by his owners. “When we first brought him to Cornell, the doctors said he 
was a couple days away from passing,” says Pressler. “Now, he’s completely bounced back and doing 
great. I give all the doctors involved a lot of credit.”
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Dr. Divers talks Theiler's disease and other liver conditions at 
AAEP convention
Dr. Thomas Divers, Steffen Professor of veterinary medicine and co-section chief of large animal 
medicine, recently provided the keynote Frank J. Milne State-of-the-Art lecture at the 2015 American 
Association of Equine Practitioner’s 61st Annual Convention in Las Vegas. His presentation, “The 
Equine Liver in health and disease” gave a thorough and comprehensive overview of the organ, its 
form, function, and pathology. The presentation was augmented with beautifully-detailed medical 
drawings done by Dr. Lauren Sawchyn ’09 and, the lecture was dedicated to the memory of Divers’ 
friend and colleague, Dr. Doug Byars, a respected equine clinician in Lexington, Kentucky.
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One of the many diseases Divers discussed 
as Theiler’s disease, a frequently fatal 
hepatic disease in adult horses with acute 
onset of clinical signs and death occurring 1-3 
days later. Frustratingly, the true cause of the 
disease had remained a mystery for nearly 
00 years. "It's the most baffling equine liver 
disease of the last century,” Divers says in his 
re. He describes the first documented 
case in South Africa, November of 1914, 
hen a condition of “acute liver atrophy” was 
recognized and reported for the first time in 
that were being used in research on 
frican horse sickness by Dr. Arnold Theiler. 
Twenty-seven horses came down with acute 
iver failure after being inoculated with anti­
serum against African horse sickness virus. 
The disease was also observed in four horses that never received any inoculations, indicating that 
Theiler’s disease could be both infectious and contagious.
Today, Theiler’s disease happens around the world and in the US every year, frequently manifesting 
as an acute hepatocellular necrosis with rapid progression to either death or in some cases complete 
recovery. In his talk, Divers describes his collaborative work with his colleague, James Law Professor 
of Comparative Medicine emeritus, Dr. Bud Tennant, in studying the condition. He lists the three types 
of cases they’ve encountered:
1) Horses that have contracted Theiler’s from blood products (serum or plasma) administered 6-10 
weeks earlier
2) Horses that have had contact with horses that had recently received blood products
3) Horses (often broodmares on pasture) with no known_recent blood product administration, often in 
the autumn season.
In the lecture, Divers describes the clinical signs (jaundice, ataxia, head pressing, seizures); 
laboratory findings (marked elevations in hepatocellular enzymes, SDH, GLDH); and available 
treatments for both liver failure and the accompanying hepatic encephalopathy.
While the exact cause of the condition is still unclear, its progression in horses with signs of liver 
failure is anything but. Divers sums up Theiler’s as an ‘all-or-nothing’ disease. “My experience is that 
horses with Theiler’s disease are usually either dead or 'on their road to recovery' within three to five 
days,” he says.
For more than 30 years, Divers and Tennant have discussed the possibility that the disease was 
caused by an unknown hepatitis virus, and that variable severity of disease may develop 4-10 weeks 
after infection due to significant antibody development and attempts to clear a virus from the liver.
The two professors, Collaborating with Novartis Human Heath Hepatitis C Research Center;
Columbia and Rockefeller Universities; the Cornell Diagnostic Laboratory, and colleagues around the 
country, have discovered not one, but two previouslyunidentified equine viruses that are associated 
with the disease. To read in detail about Theiler’s disease and many other equine liver diseases , their 
causes, signs, symptoms, and treatments, read Diver’s full lecture here.
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Latest clinical trials at CUHA
CUHA and College rely on the referral community for the successes of our clinical projects. We 
encourage referring veterinarians to look over the current clinical trials below to see if any of their 
patients may qualify; when studies are completed, we encourage patients to return to their referring 
veterinarians for continued care.
• Dr. Robert Goaas is currently recruiting doas for who suffer trauma. Clinicians need 
better markers of prognosis for injured dogs and a potential option is the measurement of blood 
concentrations of cell-free DNA. Goggs has previously shown that cell-free DNA is increased in 
the blood of dogs after trauma. He is investigating if higher blood concentrations are associated 
with complications and outcome. The study aims to determine if blood cell-free DNA can be
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accurately measured at the bedside and to determine if this biomarker is prognostic. Any dog 
admitted to the hospital with moderate to severe trauma is eligible and the study will pay for a 
complete blood count and biochemistry panel, worth over $100.
• Dr. Goggs, along with Dr. Erica Behling-Kelly, 
is recruiting all dogs with primary immune- 
mediated hemolytic anemia (IMHA). Their 
study examines a possible future treatment for 
dogs with (IMHA). In an analogous human 
disease, an inhibitor of the complement 
system has revolutionized therapy and saved 
lives. Goggs hopes to eventually treat dogs in 
a similar way. To achieve that, he and Behling- 
Kelly are testing inhibitors of canine 
complement. They also need to be able to 
identify which dogs with IMHA have high 
levels of complement activation. They are 
testing the levels of complement activation in dogs with IMHA and will also determine if blood 
concentrations of these complement proteins are associated with outcome. They are recruiting 
all dogs with primary IMHA and all complement testing will be performed free of charge.
• Dr. John Loftus and Dr. Joe Wakshlag are recruiting dogs with auto immune diseases. Their 
research examines vitamin D levels in dogs with auto immune diseases. Vitamin D not only 
plays a role in regulating calcium in the body, but also promotes a healthy immune system. Low 
levels have been associated with autoimmune disease in people, however it is unknown if this 
occurs in dogs and what role that may play in promoting autoimmunity. This study seeks to 
determine blood levels of vitamin D in dogs with immune mediated disease, and the levels will 
then be compared to patient outcomes to evaluate relationship to prognosis. The cost of vitamin 
D level testing is covered by the study and patients enrolled may be contacted for up to two 
years.
For information on these and other clinical trials, visit our website at vet.cornell.edu/clinicaltrials or 
email vet-research@cornell.edu.
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Mark your calendar for the New York State Veterinary 
Conference
The 3rd Annual Spring New York State Veterinary 
Conference, co-hosted by the New York State Veterinary 
Medical Society and Cornell University College of 
'eterinary Medicine, is fast-approaching. Held May 13-15th 
lat the Hilton Westchester in Rye Brook, NY, this year’s 
event will feature over 50 companion animal sessions for 
|the whole veterinary team.
Speaker topics will range from everyday technology in your 
practice to end-of-life care. All-new master classes, led by
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Dr. Ranee Sellon, will allow participants to explore real cases with a small group of colleagues. 
Additionally, over fifty vendors will be showcasing new products and services, and special events will 
include a Friday evening welcome reception, as well as the annual Purple Party and silent auction. 
Register at www.vet.cornell.edu/nysvc
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Animal Health Diagnostic Center provides latest info on canine 
flu, cutting-edge testing
JFighting the flu: Cornell and the Animal Health Diagnostic Center 
■(AHDC) can help you stay at the forefront of the fight against canine 
■influenza. The AHDC provides a serologic assay that detects antibodies 
nto the newly identified H3N2 influenza virus, and up-to-date surveillance 
l [data on where the latest cases of H3N2 have occurred. Stay up-to-date, 
iiand keep your patients protected. Visit the AHDC’s canine influenza info 
![page for more details.
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Helping understand equine hepatitis: There are four equine viruses potentially linked to liver 
disease that currently prove difficult to establish in an in vitro culture system. The AHDC is actively 
working to validate PCR tests for detecting these viruses. They provide testing services to 
practitioners who wish to explore the clinical relevance of these agents. Visit the AHDC’s site on the 
development of the equine hepatitis virus test to learn more.
Quicker testing for clients: The AHDC has launched OpenArray®, a next-generation molecular 
testing platform that enables streamlined and expanded syndromic PCR panels, while keeping costs 
down. Additionally, turnaround for additional requested tests may be much faster. Click here to learn 
more about the new functionality.
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